Cordasco Financial Network’s Kazia Therapeutics KZIA Stock Holding History

Cordasco Financial Network’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Hold	3	–	–	﹤0.01%	562
2022 Q1	$1K	Buy	+3	New	+$1.07K	﹤0.01%	533

Other funds holding KZIA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cordasco Financial Network's KZIA Position: Q2 2022 in Review

Cordasco Financial Network held its Kazia Therapeutics (KZIA) position steady in Q2 2022 at 3 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Cordasco Financial Network first reported a position in KZIA in Q1 2022 and has held it in 2 quarters since. 11 funds tracked by Wall St. Rank hold KZIA as of Q2 2022.

Cordasco Financial Network held 3 shares of Kazia Therapeutics worth $1K as of Q2 2022.
Cordasco Financial Network left its Kazia Therapeutics share count unchanged in Q2 2022.
Kazia Therapeutics made up ﹤0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #562 holding.
Cordasco Financial Network first reported a position in Kazia Therapeutics in Q1 2022 and has held it in 2 quarters since.
11 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.